Literature DB >> 15583166

Transcriptional and translational analysis of the ccaR gene from Streptomyces clavuligerus.

Liru Wang1, Kapil Tahlan, Tracy L Kaziuk, Dylan C Alexander, Susan E Jensen.   

Abstract

CcaR is a positive-acting transcriptional regulator involved in cephamycin C and clavulanic acid biosynthesis in Streptomyces clavuligerus. Previous sequence analyses of the ccaR gene revealed two possible start codons, an ATG, and a GTG located in-frame 18 bp downstream of the ATG. To determine the true start codon, ccaR was expressed, either from the GTG or ATG codon, in Escherichia coli. A protein product was only obtained from the ATG construct. Similarly, ccaR constructs originating from ATG or GTG and designed for expression from a glycerol-regulated promoter in Streptomyces species were prepared and used to complement a S. clavuligerus ccaR mutant. Bioassays showed that only the ATG construct could complement the ccaR mutant to restore cephamycin C production, and Western analysis confirmed the presence of CcaR in the mutant complemented with the ATG construct only. To ensure that expression of ccaR from its native promoter also initiated at the ATG rather than GTG, a conservative point mutation was introduced into ccaR, converting the GTG to GTC. The GTC construct still fully complemented a ccaR mutant, confirming that ATG is the true start codon. Inspection of the region upstream of ccaR by S1 nuclease protection and primer extension analyses indicated the presence of two transcript start points that mapped to residues located 74 and 173 bp upstream of the ATG codon.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583166     DOI: 10.1099/mic.0.27245-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  8 in total

1.  Expression of ccaR, encoding the positive activator of cephamycin C and clavulanic acid production in Streptomyces clavuligerus, is dependent on bldG.

Authors:  Dawn R D Bignell; Kapil Tahlan; Kimberley R Colvin; Susan E Jensen; Brenda K Leskiw
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  5S clavam biosynthesis is controlled by an atypical two-component regulatory system in Streptomyces clavuligerus.

Authors:  Thomas Kwong; Nathan J Zelyas; Hui Cai; Kapil Tahlan; Annie Wong; Susan E Jensen
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

3.  Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism.

Authors:  Mamoru Komatsu; Takuma Uchiyama; Satoshi Omura; David E Cane; Haruo Ikeda
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

4.  pcd mutants of Streptomyces clavuligerus still produce cephamycin C.

Authors:  Dylan C Alexander; Cecilia L Anders; Linda Lee; Susan E Jensen
Journal:  J Bacteriol       Date:  2007-06-15       Impact factor: 3.490

Review 5.  Regulatory mechanisms controlling antibiotic production in Streptomyces clavuligerus.

Authors:  Paloma Liras; Juan P Gomez-Escribano; Irene Santamarta
Journal:  J Ind Microbiol Biotechnol       Date:  2008-04-30       Impact factor: 3.346

6.  Molecular Analysis of the Clavulanic Acid Regulatory Gene Isolated from an Iranian Strain of Streptomyces Clavuligerus , PTCC 1709.

Authors:  Zohreh Hojati; Zahra Salehi; Majid Motovali-Bashi; Hasan Korbekandi; Saeed Jami
Journal:  Cell J       Date:  2011-09-23       Impact factor: 2.479

7.  Comparative Genomics and Metabolomics Analyses of Clavulanic Acid-Producing Streptomyces Species Provides Insight Into Specialized Metabolism.

Authors:  Nader F AbuSara; Brandon M Piercey; Marcus A Moore; Arshad Ali Shaikh; Louis-Félix Nothias; Santosh K Srivastava; Pablo Cruz-Morales; Pieter C Dorrestein; Francisco Barona-Gómez; Kapil Tahlan
Journal:  Front Microbiol       Date:  2019-11-08       Impact factor: 5.640

8.  Streptomyces clavuligerus: The Omics Era.

Authors:  Paloma Liras; Juan F Martín
Journal:  J Ind Microbiol Biotechnol       Date:  2021-12-23       Impact factor: 4.258

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.